Health, disease and the development of medicines Study Guide

The development of new medicines, including antibiotics, is a complex, multi-stage process designed to ensure safety and effectiveness. It begins with drug discovery, which involves identifying potential compounds that could treat a disease. This stage often includes extensive research into disease mechanisms and the screening of numerous chemicals or natural products. Once a promising compound is identified, it moves into preclinical testing. This phase involves laboratory studies using cells and tissues, as well as tests on live animals. The purpose of preclinical testing is to gather initial data on the drug's efficacy, toxicity, and pharmacokinetics (how the body absorbs, distributes, metabolises, and excretes the drug). If preclinical results are favourable, the drug progresses to clinical testing, which involves human volunteers. Clinical trials are typically divided into three phases, each with increasing numbers of participants and more extensive safety and efficacy evaluation. Throughout these stages, rigorous protocols and ethical considerations are paramount to protect participants and ensure reliable data.

Cardiovascular disease (CVD) encompasses conditions affecting the heart and blood vessels, often linked to lifestyle factors like diet and exercise. Treatment approaches are varied and often combined, including medication, surgical interventions, and significant lifestyle modifications. Medications such as statins help lower cholesterol, while antihypertensives manage high blood pressure. Surgical options range from fitting stents to open-heart bypass surgery, aiming to restore blood flow. Lifestyle changes, including a balanced diet, stopping smoking, and regular physical activity, are crucial for prevention, management and maintaining long-term health, sometimes reducing the need for more invasive treatments. Each approach has distinct benefits, drawbacks, and suitability depending on the individual's condition and overall health.